Medical Care

Global Intra-abdominal Infection Treatment Drugs Market Research Report 2025

The global market for Intra-abdominal Infection Treatment Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Intra-abdominal Infection Treatment Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intra-abdominal Infection Treatment Drugs.
The Intra-abdominal Infection Treatment Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Intra-abdominal Infection Treatment Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intra-abdominal Infection Treatment Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZeneca
Merck
Pfizer
AtoxBio
Dainippon Sumitomo Pharma
Bayer
Bristol-Myers Squibb
Mylan Pharmaceuticals Inc.
Sun Pharmaceutical Industries, Inc.
Teva Pharmaceutical Industries
Dr. Reddy’s Laboratories
Roche Holding AG
GlaxoSmithKline
Sanofi
Segment by Type
Chloramphenicol
Beta Lactums
Quinolones
Aminoglycosides
Others
Segment by Application
Intra-abdominal Abscess
Appendicitis
Diverticulitis
Diarrhea
Food Poisoning
Infection by Helicobacter Pylori
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Intra-abdominal Infection Treatment Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Intra-abdominal Infection Treatment Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Chloramphenicol
1.2.3 Beta Lactums
1.2.4 Quinolones
1.2.5 Aminoglycosides
1.2.6 Others
1.3 Market by Application
1.3.1 Global Intra-abdominal Infection Treatment Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Intra-abdominal Abscess
1.3.3 Appendicitis
1.3.4 Diverticulitis
1.3.5 Diarrhea
1.3.6 Food Poisoning
1.3.7 Infection by Helicobacter Pylori
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Intra-abdominal Infection Treatment Drugs Market Perspective (2020-2031)
2.2 Global Intra-abdominal Infection Treatment Drugs Growth Trends by Region
2.2.1 Global Intra-abdominal Infection Treatment Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Intra-abdominal Infection Treatment Drugs Historic Market Size by Region (2020-2025)
2.2.3 Intra-abdominal Infection Treatment Drugs Forecasted Market Size by Region (2026-2031)
2.3 Intra-abdominal Infection Treatment Drugs Market Dynamics
2.3.1 Intra-abdominal Infection Treatment Drugs Industry Trends
2.3.2 Intra-abdominal Infection Treatment Drugs Market Drivers
2.3.3 Intra-abdominal Infection Treatment Drugs Market Challenges
2.3.4 Intra-abdominal Infection Treatment Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Intra-abdominal Infection Treatment Drugs Players by Revenue
3.1.1 Global Top Intra-abdominal Infection Treatment Drugs Players by Revenue (2020-2025)
3.1.2 Global Intra-abdominal Infection Treatment Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Intra-abdominal Infection Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Intra-abdominal Infection Treatment Drugs Revenue
3.4 Global Intra-abdominal Infection Treatment Drugs Market Concentration Ratio
3.4.1 Global Intra-abdominal Infection Treatment Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Intra-abdominal Infection Treatment Drugs Revenue in 2024
3.5 Global Key Players of Intra-abdominal Infection Treatment Drugs Head office and Area Served
3.6 Global Key Players of Intra-abdominal Infection Treatment Drugs, Product and Application
3.7 Global Key Players of Intra-abdominal Infection Treatment Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Intra-abdominal Infection Treatment Drugs Breakdown Data by Type
4.1 Global Intra-abdominal Infection Treatment Drugs Historic Market Size by Type (2020-2025)
4.2 Global Intra-abdominal Infection Treatment Drugs Forecasted Market Size by Type (2026-2031)
5 Intra-abdominal Infection Treatment Drugs Breakdown Data by Application
5.1 Global Intra-abdominal Infection Treatment Drugs Historic Market Size by Application (2020-2025)
5.2 Global Intra-abdominal Infection Treatment Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Intra-abdominal Infection Treatment Drugs Market Size (2020-2031)
6.2 North America Intra-abdominal Infection Treatment Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Intra-abdominal Infection Treatment Drugs Market Size by Country (2020-2025)
6.4 North America Intra-abdominal Infection Treatment Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Intra-abdominal Infection Treatment Drugs Market Size (2020-2031)
7.2 Europe Intra-abdominal Infection Treatment Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Intra-abdominal Infection Treatment Drugs Market Size by Country (2020-2025)
7.4 Europe Intra-abdominal Infection Treatment Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Intra-abdominal Infection Treatment Drugs Market Size (2020-2031)
8.2 Asia-Pacific Intra-abdominal Infection Treatment Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Intra-abdominal Infection Treatment Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Intra-abdominal Infection Treatment Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Intra-abdominal Infection Treatment Drugs Market Size (2020-2031)
9.2 Latin America Intra-abdominal Infection Treatment Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Intra-abdominal Infection Treatment Drugs Market Size by Country (2020-2025)
9.4 Latin America Intra-abdominal Infection Treatment Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Intra-abdominal Infection Treatment Drugs Market Size (2020-2031)
10.2 Middle East & Africa Intra-abdominal Infection Treatment Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Intra-abdominal Infection Treatment Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Intra-abdominal Infection Treatment Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Intra-abdominal Infection Treatment Drugs Introduction
11.1.4 AstraZeneca Revenue in Intra-abdominal Infection Treatment Drugs Business (2020-2025)
11.1.5 AstraZeneca Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Intra-abdominal Infection Treatment Drugs Introduction
11.2.4 Merck Revenue in Intra-abdominal Infection Treatment Drugs Business (2020-2025)
11.2.5 Merck Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Intra-abdominal Infection Treatment Drugs Introduction
11.3.4 Pfizer Revenue in Intra-abdominal Infection Treatment Drugs Business (2020-2025)
11.3.5 Pfizer Recent Development
11.4 AtoxBio
11.4.1 AtoxBio Company Details
11.4.2 AtoxBio Business Overview
11.4.3 AtoxBio Intra-abdominal Infection Treatment Drugs Introduction
11.4.4 AtoxBio Revenue in Intra-abdominal Infection Treatment Drugs Business (2020-2025)
11.4.5 AtoxBio Recent Development
11.5 Dainippon Sumitomo Pharma
11.5.1 Dainippon Sumitomo Pharma Company Details
11.5.2 Dainippon Sumitomo Pharma Business Overview
11.5.3 Dainippon Sumitomo Pharma Intra-abdominal Infection Treatment Drugs Introduction
11.5.4 Dainippon Sumitomo Pharma Revenue in Intra-abdominal Infection Treatment Drugs Business (2020-2025)
11.5.5 Dainippon Sumitomo Pharma Recent Development
11.6 Bayer
11.6.1 Bayer Company Details
11.6.2 Bayer Business Overview
11.6.3 Bayer Intra-abdominal Infection Treatment Drugs Introduction
11.6.4 Bayer Revenue in Intra-abdominal Infection Treatment Drugs Business (2020-2025)
11.6.5 Bayer Recent Development
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Details
11.7.2 Bristol-Myers Squibb Business Overview
11.7.3 Bristol-Myers Squibb Intra-abdominal Infection Treatment Drugs Introduction
11.7.4 Bristol-Myers Squibb Revenue in Intra-abdominal Infection Treatment Drugs Business (2020-2025)
11.7.5 Bristol-Myers Squibb Recent Development
11.8 Mylan Pharmaceuticals Inc.
11.8.1 Mylan Pharmaceuticals Inc. Company Details
11.8.2 Mylan Pharmaceuticals Inc. Business Overview
11.8.3 Mylan Pharmaceuticals Inc. Intra-abdominal Infection Treatment Drugs Introduction
11.8.4 Mylan Pharmaceuticals Inc. Revenue in Intra-abdominal Infection Treatment Drugs Business (2020-2025)
11.8.5 Mylan Pharmaceuticals Inc. Recent Development
11.9 Sun Pharmaceutical Industries, Inc.
11.9.1 Sun Pharmaceutical Industries, Inc. Company Details
11.9.2 Sun Pharmaceutical Industries, Inc. Business Overview
11.9.3 Sun Pharmaceutical Industries, Inc. Intra-abdominal Infection Treatment Drugs Introduction
11.9.4 Sun Pharmaceutical Industries, Inc. Revenue in Intra-abdominal Infection Treatment Drugs Business (2020-2025)
11.9.5 Sun Pharmaceutical Industries, Inc. Recent Development
11.10 Teva Pharmaceutical Industries
11.10.1 Teva Pharmaceutical Industries Company Details
11.10.2 Teva Pharmaceutical Industries Business Overview
11.10.3 Teva Pharmaceutical Industries Intra-abdominal Infection Treatment Drugs Introduction
11.10.4 Teva Pharmaceutical Industries Revenue in Intra-abdominal Infection Treatment Drugs Business (2020-2025)
11.10.5 Teva Pharmaceutical Industries Recent Development
11.11 Dr. Reddy’s Laboratories
11.11.1 Dr. Reddy’s Laboratories Company Details
11.11.2 Dr. Reddy’s Laboratories Business Overview
11.11.3 Dr. Reddy’s Laboratories Intra-abdominal Infection Treatment Drugs Introduction
11.11.4 Dr. Reddy’s Laboratories Revenue in Intra-abdominal Infection Treatment Drugs Business (2020-2025)
11.11.5 Dr. Reddy’s Laboratories Recent Development
11.12 Roche Holding AG
11.12.1 Roche Holding AG Company Details
11.12.2 Roche Holding AG Business Overview
11.12.3 Roche Holding AG Intra-abdominal Infection Treatment Drugs Introduction
11.12.4 Roche Holding AG Revenue in Intra-abdominal Infection Treatment Drugs Business (2020-2025)
11.12.5 Roche Holding AG Recent Development
11.13 GlaxoSmithKline
11.13.1 GlaxoSmithKline Company Details
11.13.2 GlaxoSmithKline Business Overview
11.13.3 GlaxoSmithKline Intra-abdominal Infection Treatment Drugs Introduction
11.13.4 GlaxoSmithKline Revenue in Intra-abdominal Infection Treatment Drugs Business (2020-2025)
11.13.5 GlaxoSmithKline Recent Development
11.14 Sanofi
11.14.1 Sanofi Company Details
11.14.2 Sanofi Business Overview
11.14.3 Sanofi Intra-abdominal Infection Treatment Drugs Introduction
11.14.4 Sanofi Revenue in Intra-abdominal Infection Treatment Drugs Business (2020-2025)
11.14.5 Sanofi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Intra-abdominal Infection Treatment Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Chloramphenicol
Table 3. Key Players of Beta Lactums
Table 4. Key Players of Quinolones
Table 5. Key Players of Aminoglycosides
Table 6. Key Players of Others
Table 7. Global Intra-abdominal Infection Treatment Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Intra-abdominal Infection Treatment Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Intra-abdominal Infection Treatment Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Intra-abdominal Infection Treatment Drugs Market Share by Region (2020-2025)
Table 11. Global Intra-abdominal Infection Treatment Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Intra-abdominal Infection Treatment Drugs Market Share by Region (2026-2031)
Table 13. Intra-abdominal Infection Treatment Drugs Market Trends
Table 14. Intra-abdominal Infection Treatment Drugs Market Drivers
Table 15. Intra-abdominal Infection Treatment Drugs Market Challenges
Table 16. Intra-abdominal Infection Treatment Drugs Market Restraints
Table 17. Global Intra-abdominal Infection Treatment Drugs Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Intra-abdominal Infection Treatment Drugs Market Share by Players (2020-2025)
Table 19. Global Top Intra-abdominal Infection Treatment Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intra-abdominal Infection Treatment Drugs as of 2024)
Table 20. Ranking of Global Top Intra-abdominal Infection Treatment Drugs Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Intra-abdominal Infection Treatment Drugs Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Intra-abdominal Infection Treatment Drugs, Headquarters and Area Served
Table 23. Global Key Players of Intra-abdominal Infection Treatment Drugs, Product and Application
Table 24. Global Key Players of Intra-abdominal Infection Treatment Drugs, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Intra-abdominal Infection Treatment Drugs Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Intra-abdominal Infection Treatment Drugs Revenue Market Share by Type (2020-2025)
Table 28. Global Intra-abdominal Infection Treatment Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Intra-abdominal Infection Treatment Drugs Revenue Market Share by Type (2026-2031)
Table 30. Global Intra-abdominal Infection Treatment Drugs Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Intra-abdominal Infection Treatment Drugs Revenue Market Share by Application (2020-2025)
Table 32. Global Intra-abdominal Infection Treatment Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Intra-abdominal Infection Treatment Drugs Revenue Market Share by Application (2026-2031)
Table 34. North America Intra-abdominal Infection Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Intra-abdominal Infection Treatment Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Intra-abdominal Infection Treatment Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Intra-abdominal Infection Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Intra-abdominal Infection Treatment Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Intra-abdominal Infection Treatment Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Intra-abdominal Infection Treatment Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Intra-abdominal Infection Treatment Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Intra-abdominal Infection Treatment Drugs Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Intra-abdominal Infection Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Intra-abdominal Infection Treatment Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Intra-abdominal Infection Treatment Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Intra-abdominal Infection Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Intra-abdominal Infection Treatment Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Intra-abdominal Infection Treatment Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 49. AstraZeneca Company Details
Table 50. AstraZeneca Business Overview
Table 51. AstraZeneca Intra-abdominal Infection Treatment Drugs Product
Table 52. AstraZeneca Revenue in Intra-abdominal Infection Treatment Drugs Business (2020-2025) & (US$ Million)
Table 53. AstraZeneca Recent Development
Table 54. Merck Company Details
Table 55. Merck Business Overview
Table 56. Merck Intra-abdominal Infection Treatment Drugs Product
Table 57. Merck Revenue in Intra-abdominal Infection Treatment Drugs Business (2020-2025) & (US$ Million)
Table 58. Merck Recent Development
Table 59. Pfizer Company Details
Table 60. Pfizer Business Overview
Table 61. Pfizer Intra-abdominal Infection Treatment Drugs Product
Table 62. Pfizer Revenue in Intra-abdominal Infection Treatment Drugs Business (2020-2025) & (US$ Million)
Table 63. Pfizer Recent Development
Table 64. AtoxBio Company Details
Table 65. AtoxBio Business Overview
Table 66. AtoxBio Intra-abdominal Infection Treatment Drugs Product
Table 67. AtoxBio Revenue in Intra-abdominal Infection Treatment Drugs Business (2020-2025) & (US$ Million)
Table 68. AtoxBio Recent Development
Table 69. Dainippon Sumitomo Pharma Company Details
Table 70. Dainippon Sumitomo Pharma Business Overview
Table 71. Dainippon Sumitomo Pharma Intra-abdominal Infection Treatment Drugs Product
Table 72. Dainippon Sumitomo Pharma Revenue in Intra-abdominal Infection Treatment Drugs Business (2020-2025) & (US$ Million)
Table 73. Dainippon Sumitomo Pharma Recent Development
Table 74. Bayer Company Details
Table 75. Bayer Business Overview
Table 76. Bayer Intra-abdominal Infection Treatment Drugs Product
Table 77. Bayer Revenue in Intra-abdominal Infection Treatment Drugs Business (2020-2025) & (US$ Million)
Table 78. Bayer Recent Development
Table 79. Bristol-Myers Squibb Company Details
Table 80. Bristol-Myers Squibb Business Overview
Table 81. Bristol-Myers Squibb Intra-abdominal Infection Treatment Drugs Product
Table 82. Bristol-Myers Squibb Revenue in Intra-abdominal Infection Treatment Drugs Business (2020-2025) & (US$ Million)
Table 83. Bristol-Myers Squibb Recent Development
Table 84. Mylan Pharmaceuticals Inc. Company Details
Table 85. Mylan Pharmaceuticals Inc. Business Overview
Table 86. Mylan Pharmaceuticals Inc. Intra-abdominal Infection Treatment Drugs Product
Table 87. Mylan Pharmaceuticals Inc. Revenue in Intra-abdominal Infection Treatment Drugs Business (2020-2025) & (US$ Million)
Table 88. Mylan Pharmaceuticals Inc. Recent Development
Table 89. Sun Pharmaceutical Industries, Inc. Company Details
Table 90. Sun Pharmaceutical Industries, Inc. Business Overview
Table 91. Sun Pharmaceutical Industries, Inc. Intra-abdominal Infection Treatment Drugs Product
Table 92. Sun Pharmaceutical Industries, Inc. Revenue in Intra-abdominal Infection Treatment Drugs Business (2020-2025) & (US$ Million)
Table 93. Sun Pharmaceutical Industries, Inc. Recent Development
Table 94. Teva Pharmaceutical Industries Company Details
Table 95. Teva Pharmaceutical Industries Business Overview
Table 96. Teva Pharmaceutical Industries Intra-abdominal Infection Treatment Drugs Product
Table 97. Teva Pharmaceutical Industries Revenue in Intra-abdominal Infection Treatment Drugs Business (2020-2025) & (US$ Million)
Table 98. Teva Pharmaceutical Industries Recent Development
Table 99. Dr. Reddy’s Laboratories Company Details
Table 100. Dr. Reddy’s Laboratories Business Overview
Table 101. Dr. Reddy’s Laboratories Intra-abdominal Infection Treatment Drugs Product
Table 102. Dr. Reddy’s Laboratories Revenue in Intra-abdominal Infection Treatment Drugs Business (2020-2025) & (US$ Million)
Table 103. Dr. Reddy’s Laboratories Recent Development
Table 104. Roche Holding AG Company Details
Table 105. Roche Holding AG Business Overview
Table 106. Roche Holding AG Intra-abdominal Infection Treatment Drugs Product
Table 107. Roche Holding AG Revenue in Intra-abdominal Infection Treatment Drugs Business (2020-2025) & (US$ Million)
Table 108. Roche Holding AG Recent Development
Table 109. GlaxoSmithKline Company Details
Table 110. GlaxoSmithKline Business Overview
Table 111. GlaxoSmithKline Intra-abdominal Infection Treatment Drugs Product
Table 112. GlaxoSmithKline Revenue in Intra-abdominal Infection Treatment Drugs Business (2020-2025) & (US$ Million)
Table 113. GlaxoSmithKline Recent Development
Table 114. Sanofi Company Details
Table 115. Sanofi Business Overview
Table 116. Sanofi Intra-abdominal Infection Treatment Drugs Product
Table 117. Sanofi Revenue in Intra-abdominal Infection Treatment Drugs Business (2020-2025) & (US$ Million)
Table 118. Sanofi Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
Table 122. Authors List of This Report


List of Figures
Figure 1. Intra-abdominal Infection Treatment Drugs Picture
Figure 2. Global Intra-abdominal Infection Treatment Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Intra-abdominal Infection Treatment Drugs Market Share by Type: 2024 VS 2031
Figure 4. Chloramphenicol Features
Figure 5. Beta Lactums Features
Figure 6. Quinolones Features
Figure 7. Aminoglycosides Features
Figure 8. Others Features
Figure 9. Global Intra-abdominal Infection Treatment Drugs Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Intra-abdominal Infection Treatment Drugs Market Share by Application: 2024 VS 2031
Figure 11. Intra-abdominal Abscess Case Studies
Figure 12. Appendicitis Case Studies
Figure 13. Diverticulitis Case Studies
Figure 14. Diarrhea Case Studies
Figure 15. Food Poisoning Case Studies
Figure 16. Infection by Helicobacter Pylori Case Studies
Figure 17. Intra-abdominal Infection Treatment Drugs Report Years Considered
Figure 18. Global Intra-abdominal Infection Treatment Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 19. Global Intra-abdominal Infection Treatment Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 20. Global Intra-abdominal Infection Treatment Drugs Market Share by Region: 2024 VS 2031
Figure 21. Global Intra-abdominal Infection Treatment Drugs Market Share by Players in 2024
Figure 22. Global Top Intra-abdominal Infection Treatment Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intra-abdominal Infection Treatment Drugs as of 2024)
Figure 23. The Top 10 and 5 Players Market Share by Intra-abdominal Infection Treatment Drugs Revenue in 2024
Figure 24. North America Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. North America Intra-abdominal Infection Treatment Drugs Market Share by Country (2020-2031)
Figure 26. United States Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Canada Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Europe Intra-abdominal Infection Treatment Drugs Market Share by Country (2020-2031)
Figure 30. Germany Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. France Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. U.K. Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Italy Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Russia Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Nordic Countries Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Intra-abdominal Infection Treatment Drugs Market Share by Region (2020-2031)
Figure 38. China Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Japan Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. South Korea Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. India Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Australia Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Latin America Intra-abdominal Infection Treatment Drugs Market Share by Country (2020-2031)
Figure 46. Mexico Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Brazil Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Middle East & Africa Intra-abdominal Infection Treatment Drugs Market Share by Country (2020-2031)
Figure 50. Turkey Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. UAE Intra-abdominal Infection Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. AstraZeneca Revenue Growth Rate in Intra-abdominal Infection Treatment Drugs Business (2020-2025)
Figure 54. Merck Revenue Growth Rate in Intra-abdominal Infection Treatment Drugs Business (2020-2025)
Figure 55. Pfizer Revenue Growth Rate in Intra-abdominal Infection Treatment Drugs Business (2020-2025)
Figure 56. AtoxBio Revenue Growth Rate in Intra-abdominal Infection Treatment Drugs Business (2020-2025)
Figure 57. Dainippon Sumitomo Pharma Revenue Growth Rate in Intra-abdominal Infection Treatment Drugs Business (2020-2025)
Figure 58. Bayer Revenue Growth Rate in Intra-abdominal Infection Treatment Drugs Business (2020-2025)
Figure 59. Bristol-Myers Squibb Revenue Growth Rate in Intra-abdominal Infection Treatment Drugs Business (2020-2025)
Figure 60. Mylan Pharmaceuticals Inc. Revenue Growth Rate in Intra-abdominal Infection Treatment Drugs Business (2020-2025)
Figure 61. Sun Pharmaceutical Industries, Inc. Revenue Growth Rate in Intra-abdominal Infection Treatment Drugs Business (2020-2025)
Figure 62. Teva Pharmaceutical Industries Revenue Growth Rate in Intra-abdominal Infection Treatment Drugs Business (2020-2025)
Figure 63. Dr. Reddy’s Laboratories Revenue Growth Rate in Intra-abdominal Infection Treatment Drugs Business (2020-2025)
Figure 64. Roche Holding AG Revenue Growth Rate in Intra-abdominal Infection Treatment Drugs Business (2020-2025)
Figure 65. GlaxoSmithKline Revenue Growth Rate in Intra-abdominal Infection Treatment Drugs Business (2020-2025)
Figure 66. Sanofi Revenue Growth Rate in Intra-abdominal Infection Treatment Drugs Business (2020-2025)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies